THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Berberine Induces G1 Arrest and Apoptosis in Human Glioblastoma T98G through Mitochondrial/Caspases Pathway...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Diet May Be the Key to Prevention and Treatment of Brain Tumors 2 April 2008 Malignant brain tumor persists...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Targeting Brain Cancer -- In-depth Doctor's Interview 20 March 2008 John Suh, M.D., a radiation oncologist,...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. 2 April 2008 ...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Dietary zinc intake and brain cancer in adults: a case-control study. 2 Aprile 2008 Dietary zinc intake and...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> MGMT Promoter Methylation Status Predicts Survival in Pediatric Glioblastoma 7 April 2008 MGMT Promoter...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Retrospective survival comparison of patients with cerebral versus cerebellar glioblastomas 7 April 2008 ...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> 'She has one year to live', The Angela MacBeth story 7 April 2008 “She has one year to live.” That’s...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells 7 April...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Russia dà ok ad Antigenics per vendita primo vaccino anti-cancro 8 April 2008 Russian regulators have...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Hypericin uptake: A prognostic marker for survival in high-grade glioma. 2 April 2008 Hypericin uptake: A...
Ho effettuato una ricerca fra le pubblicazioni scentifiche su PubMed relativamente al St. John's Wort e il glioblastoma. Sono disponibili solamente quattro...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults 10...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Oncothyreon's PX-478 enhances antitumor effects of radiation therapy in preclinical models of pancreatic...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Oncolin Therapeutics Lead Cancer Technology 15 April 2008 Oncolin Therapeutics, Inc. announces that a...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Alternating Electric Fields Shrink Recurrent Glioblastoma Tumors 14 April 2008 An investigational device in...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma 15 April 2008 ...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> A Multidisciplinary Phase II Study of AZD2171 (cediranib), an Oral Pan-VEGF Receptor Tyrosine Kinase...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Medicor Cancer Centre's Observational DCA Treatment Data 20 March 2008 This is our second DCA data analysis...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Patient Trial For Virus That Attacks Brain Cancer Cells 16 April 2008 A common, naturally occurring virus...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Methylgene Presents Preclinical Data for Its Multi-targeted (C-Met) Kinase Inhibitor, Mgcd265, at AACR...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Research suggests breathing in pollution could trigger brain cancer 21 April 2007 Dr. Julia Ljubimova found...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Improving Quality Of Life For Brain Tumor Patients 21 April 2008 Brain tumour surgery requires a delicate...
THE GLIOBLASTOMA GROUP <http://www.glioblastoma.it> Ark Therapeutics says Cerepro paediatric study given EU clearance 22 April 2008 Ark Therapeutics Group plc...